US Patent No: 5,965,163

Number of patents in Portfolio can not be more than 2000

Substained release compositions and a method of preparing pharmaceutical compositions

1 Status Updates

Stats

ATTORNEY / AGENT: (SPONSORED)
 

Importance

Loading Importance Indicators... loading....

Abstract

A process for the manufacture of particles comprises mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixture so as to form agglomerates, breaking the agglomerates to give controlled release particles and optionally continuing the mechanical working with the optional addition of a low percentage of the carrier or diluent.

Loading the Abstract Image... loading....

First Claim

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent OwnerAddressTotal Patents
EURO-CELTIQUE S.A.LUXEMBOURG160

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Challis, Deborah Kent, GB2 5 207
Heafield, Joanne Cambridge, GB2 11 375
Knott, Trevor John Wickford, GB2 11 331
Leslie, Stewart Thomas Cambridge, GB 21 572
Malkowska, Sandra Therese Antoinette Cambridge, GB 15 478
Miller, Ronald Brown Basel, CH 18 545
Prater, Derek Allan Cambridge, GB 28 577

Cited Art

Patent Info (Count) # Cites Year
 
PURDUE PHARMA L.P. (9)
4,828,836 Controlled release pharmaceutical composition 127 1987
4,834,985 Controlled release pharmaceutical composition 160 1987
4,990,341 Controlled release hydromorphone composition 83 1989
5,266,331 Controlled release oxycodone compositions 91 1991
5,273,760 Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer 123 1991
5,286,493 Stabilized controlled release formulations having acrylic polymer coating 124 1992
5,549,912 Controlled release oxycodone compositions 79 1993
5,580,578 Controlled release formulations coated with aqueous dispersions of acrylic polymers 96 1993
5,639,476 Controlled release formulations coated with aqueous dispersions of acrylic polymers 233 1995
 
EURO-CELTIQUE S.A. (4)
4,844,907 Pharmaceutical composition comprising analgesic and anti-inflammatory agent 97 1986
5,500,227 Immediate release tablet cores of insoluble drugs having sustained-release coating 92 1993
5,849,240 Method of preparing sustained release pharmaceutical compositions 58 1996
5,843,480 Controlled release diamorphine formulation 41 1996
 
ALPHARMA PHARMACEUTICALS, LLC (2)
5,202,128 Sustained release pharmaceutical composition 111 1990
5,330,766 Sustained release pharmaceutical composition 74 1993
 
BASF AKTIENGESELLSCHAFT (2)
4,801,460 Preparation of solid pharmaceutical forms 109 1987
5,073,379 Continuous preparation of solid pharmaceutical forms 79 1989
 
GLATT GMBH (2)
4,967,486 Microwave assisted fluidized bed processor 32 1989
5,132,142 Apparatus and method for producing pellets by layering power onto particles 44 1991
 
PURDUE PHARMA COMPANY, THE (2)
4,861,598 Controlled release bases for pharmaceuticals 95 1986
4,970,075 Controlled release bases for pharmaceuticals 74 1989
 
SCHWARZ PHARMA AG (2)
5,453,283 Orally administered solvent-free pharmaceutical preparation with delayed active-substance release, and a method of preparing the preparation 20 1993
5,472,710 Pharmaceutical preparation to be administered orally with controlled release of active substance and method for its manufacture 43 1994
 
WARNER-LAMBERT COMPANY (2)
4,483,847 Process for the manufacture of a pharmaceutical composition with a retarded liberation of active material 62 1983
5,167,964 Semi-enteric drug delivery systems and methods for preparing same 65 1992
 
YAMANOUCHI PHARMACEUTICAL CO., LTD. (2)
4,343,789 Sustained release pharmaceutical composition of solid medical material 72 1980
4,380,534 Solid drug preparations 40 1981
 
AKZO N.V. (1)
4,613,619 Anti-arrhythmic amino-alcohols 19 1985
 
ALFA WASSERMANN S.P.A. (1)
5,300,300 Controlled release gastroresistant pharmaceutical formulations for oral administration containing bile acids and their salts 28 1992
 
CADBURY ADAMS USA LLC (1)
4,894,234 Novel drug delivery system for antiarrhythmics 65 1988
 
CIBA SPECIALTY CHEMICALS CORPORATION (1)
4,310,483 Thermal tumbling granulation 34 1979
 
DEPOMED SYSTEMS, INC. (1)
5,007,790 Sustained-release oral drug dosage form 130 1989
 
DRUGTECH CORPORATION (1)
5,133,974 Extended release pharmaceutical formulations 197 1990
 
DUQUESNE UNIVERSITY OF THE HOLY GHOST, A CORP. OF PA. (1)
5,169,645 Directly compressible granules having improved flow properties 80 1989
 
ELAN PHARMA INTERNATIONAL LIMITED (1)
4,917,899 Controlled absorption diltiazem formulation 52 1987
 
ETHICAL PHARMACEUTICALS LIMITED (1)
4,880,830 Slow release formulation 45 1987
 
EUROCELTIQUE S.A., 122, BOULEVARD DE LA PETRUSSE, LUXEMBOURG (1)
4,844,909 Controlled release hydromorphone composition 77 1987
 
F.H. FAULDING & CO. LIMITED (1)
5,196,203 Theophylline dosage form 37 1991
 
FOREST LABORATORIES, INC. (1)
4,389,393 Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose 206 1982
 
GACELL LABORATORIES AB (1)
5,178,868 Dosage form 51 1991
 
HOECHST AKTIENGESELLSCHAFT (1)
4,935,246 Process for the coating of granules 99 1988
 
INDRESCO, INC. (1)
4,329,794 Ripping attachment for dragline 28 1980
 
MERRELL DOW PHARMACEUTICALS INC. (1)
4,421,736 Sustained release diethylpropion compositions 53 1982
 
MITSUI CHEMICALS, INC. (1)
4,621,114 Propylene resin composition 33 1984
 
NAPP PHARMACEUTICAL GROUP LIMITED (1)
5,591,452 Controlled release formulation 50 1994
 
NIRO HOLDING A/S (1)
5,030,400 Process and an apparatus for agglomeration of a powdery material 57 1990
 
NOVARTIS AG (1)
5,403,593 Melt granulated compositions for preparing sustained release dosage forms 28 1992
 
ORTHO PHARMACEUTICAL CORPORATION (1)
5,395,626 Multilayered controlled release pharmaceutical dosage form 88 1994
 
PHARMACIA AB (1)
5,807,583 Process for the preparation of sustained release pellets 8 1995
 
PHARMASCIENCES, INC. (1)
4,925,675 Erythromycin microencapsulated granules 28 1988
 
PUREUE PHARMA L.P. (1)
4,834,984 Controlled release dihydrocodeine composition 73 1987
 
REVLON CONSUMER PRODUCTS CORPORATION (1)
5,271,934 Encapsulated antiperspirant salts and deodorant/antiperspirants 75 1992
 
SANKYO COMPANY, LIMITED (1)
4,533,562 Method of preparing coated solid preparations 47 1984
 
SANSHO CO., LTD. (1)
5,204,119 External preparation comprising calcium silicate 33 1991
 
SCHERING CORPORATION (1)
5,162,117 Controlled release flutamide composition 50 1991
 
SHIONOGI & CO., LTD. (1)
5,023,089 Sustained-release preparations and the process thereof 44 1989
 
SPRING AG, PHARMAZEUTISCHE PRAEPARATE A SWISS CORP. (1)
5,292,461 Process for the production of pellets 46 1991
 
TAKEDA CHEMICAL INDUSTRIES, LTD. (1)
5,443,846 Granulated preparations and method of producing the same 19 1994
 
TAKEDA PHARMACEUTICAL COMPANY LIMITED (1)
5,026,560 Spherical granules having core and their production 96 1988
 
TCF BANK SAVINGS FSB N/K/A TCF NATIONAL BANK (1)
5,126,145 Controlled release tablet containing water soluble medicament 96 1990
 
TEIJIN LIMITED (1)
4,801,458 Sustained release pharmaceutical plaster 89 1987
 
THE ROCKEFELLER UNIVERSITY (1)
4,987,136 Method for controlling gastrointestinal dysmotility 80 1986
 
THE UPJOHN COMPANY (1)
4,366,172 4-Amino-cyclohexanols, their pharmaceutical compositions and methods of use 28 1977
 
OTHER [CHECK PATENT PROFILE FOR ASSIGNMENT INFORMATION] (1)
4,259,314 Method and composition for the preparation of controlled long-acting pharmaceuticals 107 1979

Patent Citation Ranking

Forward Cites

Patent Info (Count) # Cites Year
 
PURDUE PHARMA L.P. (28)
6,143,322 Method of treating humans with opioid formulations having extended controlled release 62 1997
7,740,881 Method of treating humans with opioid formulations having extended controlled release 1 2000
6,696,088 Tamper-resistant oral opioid agonist formulations 45 2001
6,733,783 Controlled release hydrocodone formulations 34 2001
7,846,476 Once-a-day oxycodone formulations 3 2002
7,943,173 Pharmaceutical combinations of oxycodone and naloxone 0 2002
7,914,818 Opioid agonist formulations with releasable and sequestered antagonist 1 2002
6,696,066 Opioid agonist/antagonist combinations 35 2002
7,514,100 Controlled release hydrocodone formulations 4 2003
7,842,311 Tamper-resistant oral opioid agonist formulations 0 2003
7,172,767 Opioid agonist / antagonist combinations 19 2003
7,842,309 Tamper-resistant oral opioid agonist formulations 0 2003
7,718,192 Tamper-resistant oral opioid agonist formulations 4 2003
7,682,632 Tamper-resistant oral opioid agonist formulations 4 2003
7,658,939 Tamper-resistant oral opioid agonist formulations 5 2003
7,943,174 Controlled release hydrocodone formulations 1 2004
7,384,653 Oral dosage form comprising a therapeutic agent and an adverse-effect agent 6 2004
7,419,686 Opioid agonist/antagonist combinations 9 2006
7,749,542 Opioid agonist/antagonist combinations 1 2008
8,389,007 Pharmaceutical composition containing gelling agent 0 2008
8,142,811 Controlled release hydrocodone formulations 0 2009
8,105,631 Opioid agonist/antagonist combinations 0 2010
8,236,351 Tamper-resistant oral opioid agonist formulations 0 2010
8,231,898 Controlled release hydrocodone formulations 0 2010
8,231,901 Opioid agonist formulations with releasable and sequestered antagonist 0 2011
8,337,888 Pharmaceutical formulation containing gelling agent 0 2012
8,361,499 Controlled release hydrocodone formulations 0 2012
8,357,399 Tamper-resistant oral opioid agonist formulations 0 2012
 
ABBVIE INC. (5)
8,377,952 Solid pharmaceutical dosage formulation 0 2005
8,333,990 Solid pharmaceutical dosage form 0 2010
8,309,613 Solid pharmaceutical dosage form 0 2010
8,399,015 Solid pharmaceutical dosage form 0 2011
8,268,349 Solid pharmaceutical dosage form 1 2012
 
ALPHARMA PHARMACEUTICALS, LLC (3)
8,158,156 Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist 0 2007
7,682,633 Pharmaceutical composition 0 2009
7,682,634 Pharmaceutical compositions 0 2009
 
DEPOMED, INC. (3)
8,377,453 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,372,432 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2009
8,394,408 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic 0 2012
 
ENDO PHARMACEUTICALS INC. (3)
7,276,250 Sustained release formulations of oxymorphone 2 2002
8,329,216 Oxymorphone controlled release formulations 0 2006
8,309,122 Oxymorphone controlled release formulations 0 2007
 
EURO-CELTIQUE S.A. (3)
6,068,855 Pharmaceutical composition containing a fusible carrier and method for producing the same 38 1997
6,162,467 Sustained release compositions and a method of preparing pharmaceutical compositions 40 1999
6,806,294 Opioid analgesic 9 2002
 
ANGELINI LABOPHARM, LLC (2)
7,829,120 Trazodone composition for once a day administration 1 2006
8,414,919 Sustained drug release composition 0 2010
 
COLLEGIUM PHARMACEUTICAL, INC. (2)
7,399,488 Abuse-deterrent pharmaceutical compositions of opiods and other drugs 5 2003
7,771,707 Abuse-deterrent drug formulations 0 2005
 
ELITE LABORATORIES INC. (2)
8,182,836 Abuse-resistant oral dosage forms and method of use thereof 0 2009
8,425,933 Abuse-resistant oral dosage forms and method of use thereof 0 2009
 
CIRC PHARMA RESEARCH AND DEVELOPMENT LIMITED (1)
6,733,789 Multiparticulate bisoprolol formulation 5 2000
 
HEXAL AG (1)
6,284,269 Pharmaceutical compositions of meloxicam with improved solubility and bioavailability 3 2000
 
NAPP PHARMACEUTICAL GROUP LIMITED (1)
7,074,430 Controlled release tramadol tramadol formulation 9 2001
 
NOSTRUM PHARMACEUTICALS, INC. (1)
7,052,706 Control release formulation containing a hydrophobic material as the sustained release agent 2 2002
 
PALADIN LABS EUROPE LIMITED (1)
7,988,998 Sustained-release tramadol formulations with 24-hour efficacy 1 2005
 
WOCKHARDT EUROPE LIMITED (1)
6,555,139 Preparation of micron-size pharmaceutical particles by microfluidization 13 1999